Edgestream Partners, L.P. Organon & Co. Transaction History
Edgestream Partners, L.P.
- $3.48 Billion
- Q2 2025
A detailed history of Edgestream Partners, L.P. transactions in Organon & Co. stock. As of the latest transaction made, Edgestream Partners, L.P. holds 10,429 shares of OGN stock, worth $114,823. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,429Holding current value
$114,823% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding OGN
# of Institutions
795Shares Held
210MCall Options Held
2.71MPut Options Held
1.79M-
Black Rock Inc. New York, NY32.6MShares$359 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$355 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA10.2MShares$113 Million0.03% of portfolio
-
State Street Corp Boston, MA9.52MShares$105 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny9.09MShares$100 Million0.05% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $2.8B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...